Adventure, Inc. Logo

Adventure, Inc.

A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.

6030 | T

Overview

Corporate Details

ISIN(s):
JP3122380003
LEI:
Country:
Japan
Address:
渋谷区恵比寿4−20−3恵比寿ガーデンプレイスタワー24F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adventure, Inc. is a Japanese online travel agency (OTA) that operates the comprehensive travel booking platform, skyticket. The platform provides a wide array of services in over 30 languages, including reservations for flights, hotels, rental cars, package tours, ferries, and WiFi rentals. A pioneer in online bookings for low-cost carriers (LCCs), the company focuses on offering competitive rates and a seamless user experience. Founded in 2006 with the philosophy of a social business, Adventure, Inc. aims to contribute to society by stimulating local economies and creating employment opportunities through the global tourism industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 07:52
Registration Form
確認書
Japanese 8.9 KB
2025-10-31 07:50
Registration Form
有価証券報告書-第19期(2024/07/01-2025/06/30)
Japanese 1.1 MB
2025-06-25 02:59
Major Shareholding Notification
変更報告書
Japanese 40.3 KB
2025-02-13 07:32
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-02-13 07:31
Interim Report
半期報告書-第19期(2024/07/01-2025/06/30)
Japanese 295.3 KB
2024-12-06 04:01
Major Shareholding Notification
変更報告書
Japanese 44.5 KB
2024-11-13 04:13
Major Shareholding Notification
大量保有報告書
Japanese 42.2 KB
2024-10-01 08:05
Regulatory News Service
臨時報告書
Japanese 25.8 KB
2024-09-27 08:22
Governance Information
内部統制報告書-第18期(2023/07/01-2024/06/30)
Japanese 23.6 KB
2024-09-27 08:20
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:19
Annual Report
有価証券報告書-第18期(2023/07/01-2024/06/30)
Japanese 1.1 MB
2024-09-13 08:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.1 KB
2024-08-15 08:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2024-05-21 08:54
Regulatory News Service
臨時報告書
Japanese 20.5 KB
2024-05-13 08:09
Report Publication Announcement
確認書
Japanese 8.8 KB

Automate Your Workflow. Get a real-time feed of all Adventure, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adventure, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adventure, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.